Forte Biosciences Inc
Biotechnology
Forte Biosciences Inc (FBRX) Stock News
The latest FBRX headlines and market coverage — 2 recent stories, updated throughout the day.
- GlobeNewswire Inc.·
Halper Sadeh LLC is Investigating Whether FBRX, LXFR, SMTI, MKTX are Obtaining Fair Deals for their Shareholders
Halper Sadeh LLC, an investor rights law firm, is investigating four companies for potential violations of federal securities laws and breaches of fiduciary duties related to their proposed acquisitions. The firm is examining whether insiders are receiving substantial benefits unavailable to ordinary shareholders and whether transaction terms limit competing offers. The investigations cover Forte Biosciences' sale to argenx, Luxfer Holdings' sale to Wynnchurch Capital affiliates, Sanara MedTech's sale to MiMedx Group, and MarketAxess Holdings' sale to Intercontinental Exchange.
- GlobeNewswire Inc.·
Halper Sadeh LLC is Investigating Whether FBRX and SAFT are Obtaining Fair Deals for their Shareholders
Halper Sadeh LLC, an investor rights law firm, is investigating Forte Biosciences' $77.00 per share sale to argenx and Safety Insurance Group's $105.00 per share sale to a Mapfre affiliate for potential securities law violations and breaches of fiduciary duties. The firm is seeking increased consideration, additional disclosures, and other relief on behalf of shareholders.